| A. | Coverage of Preventive Health Services for Pregnant Women |
| Service | Age/Sex | Interval/Limits | Policy | Risk Factors | Procedure Code(s) | Diagnosis Code(s) |
1. Screening for anemia during pregnancy USPSTF Recommendation: Routine screening for iron deficiency anemia in asymptomatic pregnant women | Pregnant women | 1 screening per pregnancy | Screening for anemia during pregnancy will be covered once per pregnancy. | None | 80055 85025 85027 85013 85014 85018 | V22.0 V22.1 V22.2 V23.0 V23.2 V23.49 V23.81 V23.82 V23.85 V23.89 V23.9 V28.0 V28.89 V28.9 V72.42 V72.69 |
2. Lactation/ breastfeeding support and counseling USPSTF Recommendation: Interventions to promote & support breastfeeding | Pregnant women and new mothers | | Covered under Healthy You! wellness benefit. Lactation/breast feeding support and interventions will be covered when provided by the inpatient hospital nursing staff and at the infant’s first Healthy You! visit at 2 weeks of age by the Healthy You! primary care provider.
Note: Breast feeding classes are offered at no-cost at many hospitals.
| None | N/A | N/A |
3. Breastfeeding equipment USPSTF Recommendation: Interventions to promote & support breastfeeding | Breastfeeding mothers | 1 per pregnancy | One manual breast pump will be covered per pregnancy. | None | E0602 | V24.1 |
4. Chlamydia Screening USPSTF Recommendation: Recommends screening for chlamydial infection for all pregnant women aged 24 and younger and for older pregnant women who are at increased risk. | All pregnant women 24 and younger and older pregnant women at increased risk | 1 screening at the 1st prenatal visit | Chlamydia screening will be covered once for pregnant women aged 24 and younger and for older pregnant women who are at increased risk. | All sexually active women 24 years of age or younger, including adolescents, are at increased risk for chlamydial infection. In addition to sexual activity and age, other risk factors for chlamydial infection include - - a history of chlamydial or other sexually transmitted infection
- new or multiple sexual partners
- inconsistent condom use
- exchanging sex for money or drugs
| 87110 87270 87320 87490 87491 87492 87810 | V20.81 V22.0 V22.1 V22.2 V23.81 V23.82 V23.89 V23.9 V28.0 V28.89 V28.9 V72.42 |
| | All pregnant women with continued risk or new risk factor | 2nd screening must be performed in the 3rd trimester | A second chlamydia screening may be conducted in the 3rd trimester for pregnant women with new or continued risk. Risk factors must be documented by the healthcare provider. | For pregnant women who remain at increased risk and for those who acquire a new risk factor, such as a new sexual partner, a screening should be conducted during the third trimester. | 87110 87270 87320 87490 87491 87492 87810 | V23.0 V23.2 V23.49 V23.81 V23.82 V23.85 V23.9 |
5. Syphilis Screening USPSTF Recommendation: Recommends that clinicians screen all pregnant women for syphilis infection. | All pregnant women | 1 screening at the 1st prenatal visit | Syphilis screening will be covered for all pregnant women at the first prenatal visit. | None | 86592 86593 80055 | V22.0 V22.1 V22.2 V23.9 V28.0 V28.89 V28.9 V72.42 |
| | High-risk pregnant women | 2nd screening in the 3rd trimester
AND 3rd screening at time of delivery included within the hospital DRG
| For women in high-risk groups, repeat serologic testing for syphilis is recommended in the third trimester and at delivery. Risk factors must be documented by the healthcare provider. | Populations at increased risk for syphilis infection may include – - commercial sex workers
- persons who exchange sex for drugs
- those in adult correctional facilities
| 86592 86593 80055 | V23.0 V23.2 V23.49 V23.81 V23.82 V23.85 V23.89 V23.9
|
6. Gonorrhea Screening USPSTF Recommendation: Recommends that clinicians screen all sexually active women, including those who are pregnant, for gonorrhea infection if they are at increased risk for infection (that is, if they are young or have other individual or population risk factors). | Sexually active women at increased risk | 1 screening at the 1st prenatal visit 2nd screening in the 3rd trimester | Gonorrhea screening will be covered for all pregnant women at increased risk for infection. The screening may be conducted twice during pregnancy according to documented risk factors by the healthcare provider. | Risk factors for gonorrhea include – - a history of previous gonorrhea infection
- other sexually transmitted infections
- new or multiple sexual partners
- inconsistent condom use
- sex work
- drug use
| 87590 87591 87592 87850 | V22.0 V22.1 V22.2 V23.0 V23.2 V23.49 V23.81 V23.82 V23.85 V23.89 V23.9 V28.9 V72.42 V73.99 |
7. Hepatitis B Screening USPSTF Recommendation: Recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit. | Pregnant women | 1 screening at the 1st prenatal visit | Hepatitis B screening will be covered for all pregnant women at the first prenatal visit. | None | 87340 80055 | V22.0 V22.1 V22.2 V23.9 V28.0 V28.89 V28.9 V72.42 |
| | High-risk pregnant women | Repeat screening at delivery - Re-screen women with unknown status or new or continuing risk factors at admission to hospital/birth center
| A second Hepatitis B screening may be conducted at admission to hospital/birth center according to documented risk factors by the healthcare provider. This is included within the hospital DRG. | Risk factors for a second hepatitis B screening include –
- Have unprotected sex with more than one partner
- Have unprotected sex with someone who's infected with HBV
- Have a sexually transmitted disease such as gonorrhea or chlamydia
- Share needles during intravenous (IV) drug use
- Share a household with someone who has a chronic HBV infection
- Have a job that exposes you to human blood
- Receive hemodialysis for end-stage kidney (renal) disease
- Travel to regions with high infection rates of HBV, such as Africa, Central and Southeast Asia, and Eastern Europe
| | |
8. HIV Screening USPSTF Recommendation: Recommends that clinicians screen for human immunodeficiency virus (HIV) all adolescents and adults at increased risk for HIV infection. | Pregnant women | 1 screening at the 1st prenatal visit | HIV screening will be covered for all pregnant women at increased risk. The screening is to be conducted once during pregnancy according to documented risk factors by the healthcare provider. | Risk factors for HIV include - - Unprotected sex with multiple partners
- Injection drug user
- Sex worker
- History of sex partners who are HIV+, bisexual, or injection drug users
- History of STDs
- Transfusion between 1978-85
- Patient requests an HIV test
| 86701 86702 86703 | V22.0 V22.1 V22.2 V23.0 V23.2 V23.49 V23.81 V23.82 V28.89 V28.9 V72.42 V23.85 V23.89 V23.9 V28.0 |
9. Rh (D) Incompatibility USPSTF Recommendation: Recommends Rh (D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care. | Pregnant women | 1 antibody testing at the 1st prenatal visit | Rh Incompatibility screening will be covered for all pregnant women. | None | 86901 86850 80055 | V22.0 V22.1 V22.2 V23.2 V23.81 V23.9 V28.89 V28.9 V72.42 |
| USPSTF Recommendation: The USPSTF recommends repeated Rh (D) antibody testing for all unsensitized Rh (D)-negative women at 24-28 weeks' gestation, unless the biological father is known to be Rh (D)-negative. | Unsensitized Rh (D)-negative pregnant women | Repeat antibody testing at 24-28 weeks’ gestation | Repeated Rh (D) antibody testing will be covered for all unsensitized Rh (D)-negative women at 24-28 weeks' gestation, unless the biological father is known to be Rh (D)-negative.
| Unsensitized Rh (D)-negative women | 86901 86850 80055 | V22.0 V22.1 V22.2 V23.2 V23.81 V23.9 V28.89 V28.9 V72.42 |
10. Bacteriuria Screening USPSTF Recommendation: Recommends screening for asymptomatic bacteriuria with urine culture for pregnant women at 12 to 16 weeks' gestation or at the first prenatal visit, if later. | Pregnant women | 1 screening per pregnancy | Bacteriuria screening will be covered for all pregnant women. The screening is to be conducted once during pregnancy, preferably at the first prenatal visit or 12-16 weeks gestation. | None | 87077 87084 87086 87088 | V22.0 V22.1 V22.2 V23.0 V23.2 V23.49 V23.81 V23.82 V23.85 V23.89 V23.9 V28.0 V28.4 V28.8 V28.81 V28.89 V28.9 V72.42 |
11. Gestational Diabetes Mellitus (GDM) Screening USPSTF Recommendation: Gestational diabetes mellitus screening at the first prenatal visit and between 24-28 weeks | Pregnant women identified to be at high risk for developing gestational diabetes mellitus | 1 screening at the 1st prenatal visit | Gestational diabetes screening will be covered at the first prenatal visit for pregnant women identified to be at high risk for developing diabetes mellitus | Risk factors for developing gestational diabetes mellitus include women who – - Are obese
- Are older than 25 years
- Have a family history of diabetes
- Have a history of gestational diabetes mellitus
- Are of certain ethnic groups (Hispanic, American Indian, Asian, or African-American)
| 82947 82948 82950 82962
| V22.0 V22.1 V22.2 V23.0 V23.1 V23.2 V23.3 V23.41 V23.42 V23.49 V23.5 V23.7 V23.81 V23.82 V23.83 V23.84 V23.85 V23.86 V23.87 V23.89 V23.9 |
| | All pregnant women | 1 screening between 24-28 weeks’ gestation | Gestational diabetes screening will be covered for all pregnant women between 24-28 weeks of pregnancy. | None | 82947 82948 82950 82962
| V22.0 V22.1 V22.2 V23.0 V23.1 V23.2 V23.3 V23.41 V23.42 V23.49 V23.5 V23.7 V23.81 V23.82 V23.83 V23.84 V23.85 V23.86 V23.87 V23.89 V23.9 |
12. Folic Acid Supplementation USPSTF Recommendation: Recommends that all women planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400 to 800 µg) of folic acid. | Women planning or capable of pregnancy | 1 tablet per day by prescription | Folic acid supplementation may be covered at least 1 month before conception and may continue up to 3 months of pregnancy. Prescription is required.
| Prescriptions will be required at the pharmacy to obtain folic acid supplements. | N/A | N/A |